2223:TADAWULSaudi Aramco Base Oil Company - Luberef Analysis
Data as of 2026-05-18 - not real-time
HK$1.01
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Casablanca Group Limited is trading at HK$1.01, comfortably above its 20‑day SMA (0.95) and 50‑day SMA (0.92) while still below the 200‑day SMA (0.64), indicating a short‑term bullish bias. Technical momentum is strong with a bullish MACD crossover (line 0.022 > signal 0.015) and rising volume, yet the RSI sits at 71, signalling that the stock is in overbought territory and may face short‑term pressure near the resistance level of 1.05. Fundamentally, the company is struggling: revenue fell 5% YoY, operating and profit margins are negative, and EPS is –0.05, reflecting ongoing profitability challenges. Despite these headwinds, the DCF‑derived fair value of 1.37 suggests the market is pricing in a discount of roughly 25%, and the price‑to‑book ratio of 0.72 points to a potential value opportunity. The balance sheet shows modest debt (DE ratio 4.6) against a solid cash position, and free cash flow remains positive, providing some cushion. Volatility is elevated at 27% over the past 30 days, but beta is low (0.49), indicating limited systematic risk. Investor sentiment is exuberant, as reflected by an “Extreme Greed” reading on the Fear & Greed Index (87). Overall, the stock presents a mixed picture: attractive valuation and technical strength offset by weak earnings and sector cyclicality.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and rising volume
- RSI indicating overbought conditions
- Proximity to technical resistance at 1.05
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value suggests ~25% upside
- Low beta and solid cash position
- Potential sector recovery in consumer cyclical space
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Negative earnings trends and margin pressure
- Undervalued price‑to‑book offering value cushion
- Need for operational turnaround to sustain growth
Key Metrics & Analysis
Financial Health
Revenue Growth-5.10%
Profit Margin-5.17%
ROE-3.85%
ROA-2.38%
Debt/Equity4.59
P/B Ratio0.7
Op. Cash FlowHK$15.5M
Free Cash FlowHK$17.8M
Technical Analysis
TrendBullish
RSI71.1
SupportHK$0.89
ResistanceHK$1.05
MA 20HK$0.95
MA 50HK$0.92
MA 200HK$0.64
MACDBullish
VolumeIncreasing
Fear & Greed Index87.29
Valuation
Fair ValueHK$1.37
GradeUndervalued
TypeValue
Risk Assessment
Beta0.49
Volatility26.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.